Meta description: regulatory update on a trial comparing nonintubated anesthesia with spontaneous ventilation to conventional intubated anesthesia for thoracoscopic sublobar resection, focusing on devices and safety.
The clinical trial record covers conditions of pulmonary nodules and lung neoplasms within the field of thoracic surgery. Interventions include nonintubated anesthesia with spontaneous ventilation and intravenous sedation or anesthesia. Regional nerve blocks such as paravertebral or intercostal blocks may be used to reduce pain and support the anesthesia plan. For airway management the laryngeal mask airway is listed as a device option for the nonintubated pathway. The conventional airway pathway includes intubated general anesthesia with a double lumen endotracheal tube while general anesthesia with neuromuscular blockade is listed as an alternative option. The sponsor is The First Affiliated Hospital of Guangzhou Medical University, and the study is noted as not yet recruiting as of February 20 2026.
What changed in anesthesia approach and device usage?
The record outlines two airway strategies for thoracoscopic sublobar resection in patients with pulmonary nodules or lung neoplasms. The nonintubated pathway relies on spontaneous ventilation with intravenous sedation or anesthesia. Regional nerve blocks such as paravertebral or intercostal blocks may be used to support analgesia and potentially reduce the need for systemic opioids. The conventional pathway relies on intubated general anesthesia with a double lumen endotracheal tube or other airway management approaches, with neuromuscular blockade used as appropriate. The materials reflect a regulatory and clinical assessment of airway management options for thoracic surgery within a trial context.
Who is affected and what is the scope of the trial?
The trial lists pulmonary nodules and lung neoplasms as conditions and centers on thoracic surgery. Interventions include both nonintubated and conventional intubated approaches, with devices such as a laryngeal mask airway for spontaneous ventilation and a double lumen endotracheal tube for controlled ventilation. The drug components include intravenous sedation or anesthesia and regional nerve blocks. The listing demonstrates how a trial frames airway management in thoracic procedures for regulatory documentation and evaluation.
What devices and safety considerations are noted?
Key devices listed include a laryngeal mask airway and a double lumen endotracheal tube, along with regional nerve block techniques. The description links these devices to specific anesthesia pathways and highlights the role of airway management in thoracic surgery safety. Sponsor and site information are included to support regulatory traceability within the trial record.
Who sponsors and what is the regulatory status?
The sponsor identified is The First Affiliated Hospital of Guangzhou Medical University. The trial is listed on ClinicalTrials.gov and is not yet recruiting as of the date provided. The listing provides a route to additional information and updates about the trial progression and status.
What are the implications for practice and regulation?
Regulators and device manufacturers may use this trial to understand interests in airway devices for nonintubated versus intubated pathways during thoracic surgery. The description shows the interplay between device selection, sedation or anesthesia strategy and analgesia techniques such as regional nerve blocks. Outcomes from this trial could influence labeling and risk management considerations for airway devices used in thoracic procedures. Clinicians should monitor the recruitment status and forthcoming results to guide policy and practice decisions.
FAQ
- 1. What is nonintubated anesthesia in this trial?
In this context nonintubated means spontaneous ventilation without using a traditional endotracheal tube for airway control. Regional nerve blocks may be used to manage pain.
- 2. Who is sponsoring this trial?
The sponsor listed is The First Affiliated Hospital of Guangzhou Medical University.
- 3. Where can I find more information?
See the ClinicalTrials.gov listing at https://clinicaltrials.gov/study/NCT07395375?term=medical+device
In summary the record outlines a regulatory and clinical comparison of anesthesia methods for thoracoscopic sublobar resection. The findings will inform device selection and safety monitoring. Stakeholders should watch for recruitment status updates and published results to guide policy and practice decisions.
Disclaimer: This article provides information for professionals and does not constitute legal advice. It reflects the source text and any cited links. If you need legal guidance consult a qualified regulator or attorney.
https://clinicaltrials.gov/study/NCT07395375?term=medical+device